Inflammation, stem cells and atherosclerosis genetics

Current Opinion in Molecular Therapeutics

Volumn 12, Issue 6, 2010, Pages 712-723

  Goldschmidt Clermont, Pascal J ^a   Seo, David M ^a   Wang, Liyong ^a   Beecham, Gary W ^a   Liu, Zhao Jun ^a   Vazquez Padron, Roberto I ^a   Dong, Chunming ^a   Hare, Joshua M ^a   Kapiloff, Michael S ^a   Bishopric, Nanette H ^a   Pericak Vance, Margaret ^a   Vance, Jeffery M ^a   Velazquez, Omaida C ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; coronary artery disease; endothelial progenitor cell; genetics; inflammation; stem cell

Indexed keywords

ANTITHROMBOCYTIC AGENT; CHEMOKINE; CIGARETTE SMOKE; CUTANEOUS T CELL ATTRACTING CHEMOKINE; CXCL1 CHEMOKINE; CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYTOKINE; GROWTH FACTOR; GUANOSINE TRIPHOSPHATE; MACROPHAGE ELASTASE; MICRORNA; OSTEOPONTIN;

ARTERY INJURY; ARTERY RECONSTRUCTION; ATHEROSCLEROSIS; B LYMPHOCYTE; CHROMOSOME 15Q; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETICS; HOMEOSTASIS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; INFLAMMATORY CELL; MACROPHAGE; OVARY CANCER; PROTEIN EXPRESSION; REVIEW; STEM CELL;

ATHEROSCLEROSIS; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFLAMMATION; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; STEM CELLS;

EID: 79952968098     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. Brown MS, Goldstein JL: Koch's postulates for cholesterol. Cell (1992) 71(2):187-188.
2. Koch R: Koch on bacteriology. Science (1890) 16(399):169-170.
3. Ross RK: Atherosclerosis-An infammatory disease. N Engl J Med (1999) 340(2):115-126.
4. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature (1993) 362(6423):801-809. (Pubitemid 23132154) (Pubitemid 23132154)
5. Ross R: The pathogenesis of atherosclerosis-An update. N Engl J Med (1986) 314(8):488-500.
6. Shindler E: Framingham heart study bibliography. Framingham Heart Study, Framingham, MA, USA (2010). www. framinghamheartstudy.org/biblio/index.html
7. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science (1997) 275(5302):964-967. (Pubitemid 27087709) (Pubitemid 27087709)
8. Libby P: Infammation in atherosclerosis. Nature (2002) 420(6917):868-874.
9. Goldschmidt-Clermont PJ, Creager MA, Losordo DW, Lam GK, Wassef M, Dzau VJ: Atherosclerosis 2005: Recent discoveries and novel hypotheses. Circulation (2005) 112(21):3348-3353. (Pubitemid 43739381) (Pubitemid 43739381)
10. Mause SF, Ritzel E, Liehn EA, Hristov M, Bidzhekov K, Müller-Newen G, Soehnlein O, Weber C: Platelet microparticles enhance the vasoregenerative potential of angiogenic early outgrowth cells after vascular injury. Circulation (2010) 122(5):495-506.
11. Hristov M, Zernecke A, Weber C: Regulation of endothelial progenitor cell homing after arterial injury. Thromb Haemost (2007) 98(2):274-277. (Pubitemid 47250227) (Pubitemid 47250227)
12. Hristov M, Zernecke A, Bidzhekov K, Liehn EA, Shagdarsuren E, Ludwig A, Weber C: Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ Res (2007) 100(4):590-597. (Pubitemid 46673269) (Pubitemid 46673269)
13. Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, Hristov M, Köppel T, Jahantigh MN, Lutgens E, Wang S et al: Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal (2009) 2(100):ra81.
14. Xiao Q, Kiechl S, Patel S, Oberhollenzer F, Weger S, Mayr A, Metzler B, Reindl M, Hu Y, Willeit J, Xu Q: Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis-Results from a large population-based study. PLoS One (2007) 2(10):e975.
15. Goldschmidt-Clermont PJ: Loss of bone marrow-derived vascular progenitor cells leads to infammation and atherosclerosis. Am Heart J (2003) 146(Suppl 4):S5-S12. (Pubitemid 37268202) (Pubitemid 37268202)
16. Seshiah PN, Kereiakes DJ, Vasudevan SS, Lopes N, Su BY, Flavahan NA, Goldschmidt-Clermont PJ: Activated monocytes induce smooth muscle cell death: Role of macrophage colony-stimulating factor and cell contact. Circulation (2002) 105(2):174-180. (Pubitemid 34084315) (Pubitemid 34084315)
17. Tabas I: Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: The importance of lesion stage and phagocytic effciency. Arterioscler Thromb Vasc Biol (2005) 25(11):2255-2264. (Pubitemid 41552640) (Pubitemid 41552640)
18. Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T, Nishimura H, Losordo DW, Asahara T, Isner JM: Statin therapy accelerates reendothelialization: A novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation (2002) 105(25):3017-3024. (Pubitemid 34693836) (Pubitemid 34693836)
19. Werner N, Priller J, Laufs U, Endres M, Böhm M, Dirnagl U, Nickenig G: Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: Effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol (2002) 22(10):1567-1572.
20. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med (2003) 348(7):593-600. (Pubitemid 36204953) (Pubitemid 36204953)
21. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P, Pippen AM, Annex BH, Dong C, Taylor DA: Aging, progenitor cell exhaustion, and atherosclerosis. Circulation (2003) 108(4):457-463. (Pubitemid 36935540) (Pubitemid 36935540)
22. Foteinos G, Hu Y, Xiao Q, Metzler B, Xu Q: Rapid endothelial turnover in atherosclerosis-prone areas coincides with stem cell repair in apolipoprotein E-defcient mice. Circulation (2008) 117(14):1856-1863. (Pubitemid 351507474) (Pubitemid 351507474)
23. Karra R, Vemullapalli S, Dong C, Herderick EE, Song X, Slosek K, Nevins JR, West M, Goldschmidt-Clermont PJ, Seo D: Molecular evidence for arterial repair in atherosclerosis. Proc Natl Acad Sci USA (2005) 102(46):16789-16794. (Pubitemid 41688855) (Pubitemid 41688855)
24. Vaughan CJ, Gotto AM Jr, Basson CT: The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol (2000) 35(1):1-10. (Pubitemid 30061252) (Pubitemid 30061252)
25. Strong JP, Malcom GT, McMahan CA, Tracy RE, Newman WP 3rd, Herderick EE, Cornhill JF: Prevalence and extent of atherosclerosis in adolescents and young adults: Implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA (1999) 281(8):727-735. (Pubitemid 29113454) (Pubitemid 29113454)
26. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of frst cardiovascular events. N Engl J Med (2002) 347(20):1557-1565. (Pubitemid 35315836) (Pubitemid 35315836)
27. Lusis AJ: Atherosclerosis. Nature (2000) 407(6801):233-241.
28. Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG: Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med (2008) 359(18) 1897-1908.
29. Langer H, May AE, Daub K, Heinzmann U, Lang P, Schumm M, Vestweber D, Massberg S, Schönberger T, Pfsterer I, Hatzopoulos AK et al: Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res (2006) 98(2):e2-e10.
30. Harrington RA, Becker RC, Cannon CP, Gutterman D, Lincoff AM, Popma JJ, Steg G, Guyatt GH, Goodman SG, American College of Chest Physicians: Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 133(6 Suppl) 670S-707S. (Pubitemid 351892975) (Pubitemid 351892975)
31. 3) odyssey: A technology-driven saga of a receptor with twists, turns, and even a bend. Blood (2008) 112(8):3011-3025.
32. Seo D, Wang T, Dressman H, Herderick EE, Iversen ES, Dong C, Vata K, Milano CA, Rigat F, Pittman J, Nevins JR et al: Gene expression phenotypes of atherosclerosis. Arterioscler Thromb Vasc Biol (2004) 24(10):1746-1747.
33. Banerjee A, Apte UM, Smith R, Ramaiah SK: Higher neutrophil infltration mediated by osteopontin is a likely contributing factor to the increased susceptibility of females to alcoholic liver disease. J Pathol (2006) 208(4):473-485. (Pubitemid 43329334) (Pubitemid 43329334)
34. Nagasaka A, Matsue H, Matsushima H, Aoki R, Nakamura Y, Kambe N, Kon S, Uede T, Shimada S: Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells. Eur J Immunol (2008) 38(2):489-499.
35. Burdo TH, Wood MR, Fox HS: Osteopontin prevents monocyte recirculation and apoptosis. J Leukoc Biol (2007) 81(6): 1504-1511. (Pubitemid 46827973) (Pubitemid 46827973)
36. Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG, Nedeau A, Thom SR, Velazquez OC: Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1α. J Clin Invest (2007) 117(5):1249-1259. (Pubitemid 46718413) (Pubitemid 46718413)
37. Veldkamp CT, Seibert C, Peterson FC, De la Cruz NB, Haugner JC 3rd, Basnet H, Sakmar TP, Volkman BF: Structural basis of CXCR4 sulfotyrosine recognition by the chemokine SDF-1/CXCL12. Sci Signal (2008) 1(37):ra4.
38. Chen Y, Rollins J, Paigen B, Wang X: Genetic and genomic insights into the molecular basis of atherosclerosis. Cell Metab (2007) 6(3):164-179. (Pubitemid 47324136) (Pubitemid 47324136)
39. Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U, Samani NJ, Gudmundsson G, Grant SF, Thorgeirsson G, Sveinbjornsdottir S et al: The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet (2004) 36(3): 233-239. (Pubitemid 38282747) (Pubitemid 38282747)
40. Aiello RJ, Bourassa PA, Lindsey S, Weng W, Freeman A, Showell HJ: Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice. Arterioscler Thromb Vasc Biol (2002) 22(3):443-449. (Pubitemid 34218752) (Pubitemid 34218752)
41. Loike JD, Cao L, Budhu S, Marcantonio EE, El Khoury J, Hoffman S, Yednock TA, Silverstein SC: Differential regulation of? integrins by chemoattractants regulates neutrophil migration through fbrin. J Cell Biol (1999) 144(5):1047-1056. (Pubitemid 29238977) (Pubitemid 29238977)
42. Von Andrian UH, Hansell P, Chambers JD, Berger EM, Torres Filho I, Butcher EC, Arfors KE: L-selectin function is required for-integrin-mediated neutrophil adhesion at physiological shear rates in vivo. Am J Physiol (1992) 263 (4 Pt 2):H1034-H1044.
43. Shah SH, Hauser ER, Crosslin D, Wang L, Haynes C, Connelly J, Nelson S, Johnson J, Gadson S, Nelson CL, Seo D et al: ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary intervention. Atherosclerosis (2008) 201(1):148-154.
44. Mehrabian M, Allayee H, Wong J, Shi W, Wang XP, Shaposhnik Z, Funk CD, Lusis AJ: Identifcation of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ Res (2002) 91(2):120-126. (Pubitemid 34827222) (Pubitemid 34827222)
45. Kuhn H, Anton M, Gerth C, Habenicht A: Amino acid differences in the deduced 5-lipoxygenase sequence of CAST atherosclerosis-resistance mice confer impaired activity when introduced into the human ortholog. Arterioscler Thromb Vasc Biol (2003) 23(6):1072-1076. (Pubitemid 36713563) (Pubitemid 36713563)
46. Ghazalpour A, Wang X, Lusis AJ, Mehrabian M: Complex inheritance of the 5-lipoxygenase locus infuencing atherosclerosis in mice. Genetics (2006) 173(2):943-951. (Pubitemid 43945909) (Pubitemid 43945909)
47. Wang L, Fan C, Topol SE, Topol EJ, Wang Q: Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science (2003) 302(5650):1578-1581. (Pubitemid 37475704) (Pubitemid 37475704)
48. Molkentin JD, Black BL, Martin JF, Olson EN: Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell (1995) 83(7):1125-1136. (Pubitemid 26007804) (Pubitemid 26007804)
49. Black BL, Olson EN: Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu Rev Cell Dev Biol (1998) 14:167-196. (Pubitemid 29001453) (Pubitemid 29001453)
50. Hauser ER, Crossman DC, Granger CB, Haines JL, Jones CJ, Mooser V, McAdam B, Winkelmann BR, Wiseman AH, Muhlestein JB, Bartel AG et al: A genomewide scan for early-onset coronary artery disease in 438 families: The GENECARD Study. Am J Hum Genet (2004) 75(3):436-447. (Pubitemid 39095819) (Pubitemid 39095819)
51. Wang L, Hauser ER, Shah SH, Pericak-Vance MA, Haynes C, Crosslin D, Harris M, Nelson S, Hale AB, Granger CB, Haines JL et al: Peakwide mapping on chromosome 3q13 identifes the kalirin gene as a novel candidate gene for coronary artery disease. Am J Hum Genet (2007) 80(4):650-663. (Pubitemid 46564402) (Pubitemid 46564402)
52. Gu Y, Filippi MD, Cancelas JA, Siefring JE, Williams EP, Jasti AC, Harris CE, Lee AW, Prabhakar R, Atkinson SJ, Kwiatkowski DJ et al: Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases. Science (2003) 302(5644) 445-449. (Pubitemid 37296270) (Pubitemid 37296270)
53. Connelly JJ, Wang T, Cox JE, Haynes C, Wang L, Shah SH, Crosslin DR, Hale AB, Nelson S, Crossman DC, Granger CB et al: GATA2 is associated with familial early-onset coronary artery disease. PLoS Genet (2006) 2(8):e139.
54. Tsai FY, Keller G, Kuo FC, Weiss M, Chen J, Rosenblatt M, Alt FW, Orkin SH: An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature (1994) 371(6494):221-226. (Pubitemid 24293019) (Pubitemid 24293019)
55. Rodrigues NP, Janzen V, Forkert R, Dombkowski DM, Boyd AS, Orkin SH, Enver T, Vyas P, Scadden DT: Haploinsuffciency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis. Blood (2005) 106(2):477-484. (Pubitemid 40981241) (Pubitemid 40981241)
56. Gumina RJ, Kirschbaum NE, Piotrowski K, Newman PJ: Characterization of the human platelet/endothelial cell adhesion molecule-1 promoter: Identifcation of a GATA-2 binding element required for optimal transcriptional activity. Blood (1997) 89(4):1260-1269. (Pubitemid 27079990) (Pubitemid 27079990)
57. Jahroudi N, Lynch DC: Endothelial-cell-specifc regulation of von Willebrand factor gene expression. Mol Cell Biol (1994) 14(2):999-1008. (Pubitemid 24036550) (Pubitemid 24036550)
58. Wang L, Hauser ER, Shah SH, Seo D, Sivashanmugam P, Exum ST, Gregory SG, Granger CB, Haines JL, Jones CJ, Crossman D et al: Polymorphisms of the tumor suppressor gene LSAMP are associated with left main coronary artery disease. Ann Hum Genet (2008) 72(Pt 4):443-453. (Pubitemid 351833743) (Pubitemid 351833743)
59. Pimenta AF, Zhukareva V, Barbe MF, Reinoso BS, Grimley C, Henzel W, Fischer I, Levitt P: The limbic system-associated membrane protein is an Ig superfamily member that mediates selective neuronal growth and axon targeting. Neuron (1995) 15(2):287-297.
60. Eagleson KL, Pimenta AF, Burns MM, Fairfull LD, Cornuet PK, Zhang L, Levitt P: Distinct domains of the limbic system-associated membrane protein (LAMP) mediate discrete effects on neurite outgrowth. Mol Cell Neurosci (2003) 24(3):725-740. (Pubitemid 37506015) (Pubitemid 37506015)
61. Kresse SH, Ohnstad HO, Paulsen EB, Bjerkehagen B, Szuhai K, Serra M, Schaefer KL, Myklebost O, Meza-Zepeda LA: LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identifed by array comparative genomic hybridization. Genes Chromosomes Cancer (2009) 48(8):679-693.
62. Ntougkos E, Rush R, Scott D, Frankenberg T, Gabra H, Smyth JF, Sellar GC: The IgLON family in epithelial ovarian cancer: Expression profles and clinicopathologic correlates. Clin Cancer Res (2005) 11(16):5764-5768. (Pubitemid 41170301) (Pubitemid 41170301)
63. Chen J, Lui WO, Vos MD, Clark GJ, Takahashi M, Schoumans J, Khoo SK, Petillo D, Lavery T, Sugimura J, Astuti D et al: The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas. Cancer Cell (2003) 4(5):405-413. (Pubitemid 37491101) (Pubitemid 37491101)
64. Busik JV, Tikhonenko M, Bhatwadekar A, Opreanu M, Yakubova N, Caballero S, Player D, Nakagawa T, Afzal A, Kielczewski J, Sochacki A et al: Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock. J Exp Med (2009) 206(13):2897-2906.
65. Shah SH, Freedman NJ, Zhang L, Crosslin DR, Stone DH, Haynes C, Johnson J, Nelson S, Wang L, Connelly JJ, Muehlbauer M et al: Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis. PLoS Genet (2009) 5(1):e1000318.
66. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, Rone J, Movafagh S, Ji H, Yeh Y, Chen WT, Kleinman HK, Grouzmann E, Grant DS: Neuropeptide Y: A novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res (1998) 83(2):187-195. (Pubitemid 28354463) (Pubitemid 28354463)
67. Movafagh S, Hobson JP, Spiegel S, Kleinman HK, Zukowska Z: Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors. FASEB J (2006) 20(11):1924-1926.
68. Ekstrand AJ, Cao R, Bjorndahl M, Nystrom S, Jonsson-Rylander AC, Hassani H, Hallberg B, Nordlander M, Cao Y: Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proc Natl Acad Sci USA (2003) 100(10):6033-6038. (Pubitemid 36576926) (Pubitemid 36576926)
69. Sutton BS, Crosslin DR, Shah SH, Nelson SC, Bassil A, Hale AB, Haynes C, Goldschmidt-Clermont PJ, Vance JM, Seo D, Kraus WE et al: Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets. Hum Mol Genet (2008) 17(9):1318-1328. (Pubitemid 351566968) (Pubitemid 351566968)
70. Stafforini DM, Satoh K, Atkinson DL, Tjoelker LW, Eberhardt C, Yoshida H, Imaizumi T, Takamatsu S, Zimmerman GA, McIntyre TM, Gray PW et al: Platelet-activating factor acetylhydrolase defciency. A missense mutation near the active site of an anti-infammatory phospholipase. J Clin Invest (1996) 97(12):2784-2791. (Pubitemid 26197091) (Pubitemid 26197091)
71. Montrucchio G, Lupia E, Battaglia E, Del Sorbo L, Boccellino M, Biancone L, Emanuelli G, Camussi G: Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model. Arterioscler Thromb Vasc Biol (2000) 20(1):80-88. (Pubitemid 30048349) (Pubitemid 30048349)
72. Montrucchio G, Lupia E, Battaglia E, Passerini G, Bussolino F, Emanuelli G, Camussi G: Tumor necrosis factor-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. J Exp Med (1994) 180(1):377-382.
73. Camussi G, Montrucchio G, Lupia E, De Martino A, Perona L, Arese M, Vercellone A, Toniolo A, Bussolino F: Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism. J Immunol (1995) 154(12):6492-6501.
74. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A, Jonasdottir A, Sigurdsson A, Baker A, Palsson A, Masson G et al: A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science (2007) 316(5830):1491-1493. (Pubitemid 46906618) (Pubitemid 46906618)
75. McPherson R, Pertsemlidis A, Kavaslar N, Stewart A, Roberts R, Cox DR, Hinds DA, Pennacchio LA, Tybjaerg-Hansen A, Folsom AR, Boerwinkle E et al: A common allele on chromosome 9 associated with coronary heart disease. Science (2007) 316(5830):1488-1491. (Pubitemid 46906617) (Pubitemid 46906617)
76. Kim WY, Sharpless NE: The regulation of INK4/ARF in cancer and aging. Cell (2006) 127(2):265-275. (Pubitemid 44572384) (Pubitemid 44572384)
77. Krimpenfort P, Ijpenberg A, Song JY, van der Valk M, Nawijn M, Zevenhoven J, Berns A: p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a. Nature (2007) 448(7156):943-946. (Pubitemid 47312779) (Pubitemid 47312779)
78. Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, Morrison SJ, Clarke MF: Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature (2003) 423(6937):302-305. (Pubitemid 40852701) (Pubitemid 40852701)
79. Liu J, Cao L, Chen J, Song S, Lee IH, Quijano C, Liu H, Keyvanfar K, Chen H, Cao LY, Ahn BH et al: Bmi1 regulates mitochondrial function and the DNA damage response pathway. Nature (2009) 459(7245):387-392.
80. Zhu S, Liu X, Li Y, Goldschmidt-Clermont PJ, Dong C: Aging in the atherosclerosis milieu may accelerate the consumption of bone marrow endothelial progenitor cells. Arterioscler Thromb Vasc Biol (2007) 27(1):113-119. (Pubitemid 46360387) (Pubitemid 46360387)
81. Menghini R, Casagrande V, Cardellini M, Martelli E, Terrinoni A, Amati F, Vasa-Nicotera M, Ippoliti A, Novelli G, Melino G, Lauro R et al: MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation (2009) 120(15):1524-1532.
82. Fu S, Zhao H, Shi J, Abzhanov A, Crawford K, Ohno-Machado L, Zhou J, Du Y, Kuo WP, Zhang J, Jiang M et al: Peripheral arterial occlusive disease: Global gene expression analyses suggest a major role for immune and infammatory responses. BMC Genomics (2008) 9:369-388.
83. Gutstein DE, Fuster V: Pathophysiology and clinical signifcance of atherosclerotic plaque rupture. Cardiovasc Res (1999) 41(2):323-333. (Pubitemid 29087329) (Pubitemid 29087329)